-
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
NBC News: Patients weren't asked why they quit taking the weight loss drugs
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Prime Therapeutics’ Clinical Insights is your trusted resource for timely, evidence based perspectives on emerging therapies and managed care strategy. The Summer 2025 issue focuses on metabolic...
-
Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings
PA Sub-Categories: Awards GLP-1 Specialty drugs Prime Article: Stories -
Drug Approvals Monthly Update: January 2024 Traditional New drugs 1/05/2024 Zelsuvmi™ (berdazimer): The FDA approved Zelsuvmi for the topical treatment of molluscum contagiosum (MC) in adult and...
Compliance / Legal
